Lymphocyte blastogenesis induced by autochthonous human solid tumor cells: Relationship to stage of disease and serum factors

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Cancer

• Publication date

  1974-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(197411)34:5<1712::AID-CNCR2820340520>3.0.CO;2-JPMID 4473262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increase of lymphocyte‐mediated tumor‐cell destruction by certain patient sera

  1973cited by this paper
• Cell‐mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma

  1973cited by this paper
• Immunotherapy of cancer in man : scientific basis and current status

  1973cited by this paper
• Tumor-associated specificity of serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors.

  1973cited by this paper
• Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.

  1973cited by this paper
• Sequential studies on cell‐mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma

  1973cited by this paper
• Cytotoxic lymphocytes in melanoma patients

  1972cited by this paper
• Serum Mediated Inhibition of the Immunological Reactions of the Patient to his Own Tumour: A Possible Role for Circulating Antigen

  1972cited by this paper
• Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy

  1972cited by this paper
• Cell-mediated immunity in malignant melanoma.

  1972cited by this paper
• DEPRESSED CELL-MEDIATED IMMUNITY IN PATIENTS WITH PRIMARY INTRACRANIAL TUMORS

  1972cited by this paper
• ANTI‐TUMOUR IMMUNOREACTIVITY IN PATIENTS WITH MALIGNANT MELANOMA

  1972cited by this paper
• Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro.

  1972cited by this paper
• Cytotoxic lymphocytes in melanoma patients.

  1972cited by this paper
• Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.

  1972cited by this paper
• Recent advances in oncology.

  1972cited by this paper
• Multifaceted Evaluation of Human Tumor Immunity Using a Salt Extracted Colon Carcinoma Antigen 1

  1972cited by this paper
• Antigen Solubilized from Human Leukemia: Lymphocyte Stimulation

  1972cited by this paper
• Cellular immunity to human sarcoma.

  1971cited by this paper
• Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis

  1971cited by this paper
• Chromosomal Control of Reversion in Transformed Cells

  1971cited by this paper
• Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant Melanoma

  1971cited by this paper
• Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

  1971cited by this paper
• Salt Extraction of Soluble HL-A Antigens

  1971cited by this paper
• Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia.

  1971cited by this paper
• Inhibition of immune responses by glutamine antagonism: effect of azotomycin on lymphocyte blastogenesis.

  1971cited by this paper
• Serum factors in tumor‐free patients cancelling the blocking of cell‐mediated tumor immunity

  1971cited by this paper
• Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells.

  1971cited by this paper
• Activation of host lymphocytes cultured with cancer cells treated with neuraminidase.

  1971cited by this paper
• In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.

  1970cited by this paper
• Regulation of antigenic expression.

  1970cited by this paper
• Tumour-distinctive cellular immunity to renal carcinoma.

  1970cited by this paper
• Influence of cell density on response of leukocytes and column-purified lymphocytes to mitogenic agents.

  1970cited by this paper
• Metastasizing Mammary Carcinomas in Rats: Induction and Study of Their Immunogenicity

  1970cited by this paper
• Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells.

  1970cited by this paper
• Mechanisms of immunologic enhancement.

  1970cited by this paper
• Indications of cellular immunological reactions against autochthonous tumour in cancer patients studied in vitro.

  1968cited by this paper
• TUMOR DISTINCTIVE ANTIGEN AND BLOOD GROUP ISOANTIGEN OF SPHINGOGLYCO-LIPID NATURE; THEIR ISOLATION AND CHARACTERIZATION:

  1968cited by this paper
• STATISTICAL METHODS

  1967cited by this paper
• One-Way Stimulation in Mixed Leukocyte Cultures

  1966cited by this paper
• Studies on the mechanism of immunological enhancement of tumor homografts. I. Specificity of immunological enhancement.

  1963cited by this paper
• Studies on the Mechanism of Immunological Enhancement of Tumor Homografts. 1. Specificity of Immunological Enhancement

  1963cited by this paper
• Immunity to methylcholanthrene-induced sarcomas.

  1957cited by this paper
• Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.

  1953cited by this paper
• Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.

  1953cited by this paper
• GROWTH-PROMOTING FUNCTION OF LEUCOCYTES

  1922cited by this paper
• THE ACTION OF VITAL STAINS BELONGING TO THE BENZIDINE GROUP.

  1914cited by this paper
• Antigen solubilized from human leukemia : lymphocyte stimulation

  year unknowncited by this paper

• Enhanced and sustained T cell activation in response to fluid shear stress

  2024cites this paper
• Lymphocyte in vitro response to human giant cell tumors.

  1996cites this paper
• Lymphocyte In Vitro Response to Human Giant Cell Tumors

  1996cites this paper
• Relationships for recombinant interleukin-2-stimulated mixed lymphocyte tumor extract reaction between peripheral blood lymphocytes and regional node lymphocytes in gastric cancer patients.

  1992cites this paper
• HLA Class II Molecules: Form and Function in Melanocytic Tumor Progression

  1990cites this paper
• Antitumor activity of regional lymph node lymphocytes in patients with lung cancer

  1988cites this paper
• In vitro generation of tumour-specific lymphocyte reactivity to colonic carcinoma cells

  1987cites this paper
• Effects of immunostimulants on the in vitro generation of cytotoxic lymphocytes against cervical cancer cell lines.

  1983cites this paper
• Immunobiology of melanoma

  1982cites this paper
• Active, specific immunotherapy of stage III breast cancer

  1980cites this paper
• Cryopreserved lymphocytes: decreased response in immune assays of a population of sarcoma patients.

  1980cites this paper
• Correlation between the mixed lymphocyte tumor cell culture reaction (MLTR) and some histological characteristics in esophageal cancer.

  1980cites this paper
• Cancer Chemo- and Immunopharmacology

  1980cites this paper
• Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.

  1980cites this paper
• Blastogenic response of spleen cells from C1300 neuroblastoma-bearing mice to tumor cells or soluble and insoluble tumor antigens.

  1979cites this paper
• Studies of lymphocyte stimulation to tumor-associated antigen

  1979cites this paper
• Lymphocyte response to autochthonous human solid tumor cells: relationship to histological types and tumor load.

  1979cites this paper
• Advantages of cryopreserved lymphocytes for sequential evaluation of human immune competence. II. Mixed lymphocyte cultures and mononuclear cell subpopulations.

  1978cites this paper
• Mixed lymphocyte--tumor cell culture reaction in cancer patients.

  1978cites this paper
• Tumor membrane lymphocyte stimulation assay in patients with renal cell carcinoma.

  1978cites this paper
• 8 – Shedding of tumor cell surface antigens

  1977cites this paper
• Current concepts of the biology of human cutaneous malignant melanoma.

  1977cites this paper
• Transfer factor: A potential agent for immunotherapy of cancer

  1977cites this paper
• A rapid assay for stimulation of human lymphocytes by tumor-associated antigens.

  1976cites this paper
• In vitro lymphocyte reactivity and T cell levels in patients with melanoma: correlations with clinical and pathological stage.

  1976cites this paper
• Immunology and immunotherapy of childhood neoplasia.

  1976cites this paper
• T and B lymphocytes in malignant melanoma patients.

  1976cites this paper
• Detection of human tumor‐associated antigens by the leukocyte migration in agarose assay

  1976cites this paper
• Immunodeficiency in cancer and the importance of immune evaluation of the cancer patient.

  1976cites this paper
• ANERGY IN CANCER

  1976cites this paper
• A Rapid Method for Establishing Short-Term Primary Cultures of Human Tumor Cells from Fresh Tumor Biopsies

  1975cites this paper
• Lymphocyte responses of lung cancer patients to tumor-associated antigen measured by leucine incorporation.

  1975cites this paper
• Effect of bacillus Calmette-Guerin immunotherapy on tumor antigen-induced lymphocyte-stimulated protein synthesis in melanoma patients.

  1975cites this paper
• Lymphocyte stimulation by autochthonous human solid tumours.

  1973cites this paper